Wave Life Sciences Second Quarter 2025 Financial Results Scheduled for July 30, 2025
Wave Life Sciences (NASDAQ:WVE), a clinical-stage biotechnology company specializing in RNA medicines, has scheduled its second quarter 2025 financial results conference call for July 30, 2025 at 8:30 a.m. ET. The company will present financial results and provide business updates during the webcast.
Investors and analysts can access the event through the company's investor relations website, with analysts having the option to participate in the Q&A session. An archived version of the webcast will be available after the live event.
Wave Life Sciences (NASDAQ:WVE), un'azienda biotecnologica in fase clinica specializzata in terapie a base di RNA, ha programmato la sua teleconferenza per la presentazione dei risultati finanziari del secondo trimestre 2025 per il 30 luglio 2025 alle 8:30 ET. Durante la diretta web, l'azienda presenter脿 i risultati finanziari e fornir脿 aggiornamenti sulle attivit脿.
Investitori e analisti potranno seguire l'evento tramite il sito web dedicato agli investitori della societ脿, con la possibilit脿 per gli analisti di partecipare alla sessione di domande e risposte. Una registrazione della diretta sar脿 disponibile dopo l'evento.
Wave Life Sciences (NASDAQ:WVE), una empresa biotecnol贸gica en etapa cl铆nica especializada en medicamentos de ARN, ha programado su conferencia telef贸nica de resultados financieros del segundo trimestre de 2025 para el 30 de julio de 2025 a las 8:30 a.m. ET. La compa帽铆a presentar谩 los resultados financieros y ofrecer谩 actualizaciones sobre el negocio durante la transmisi贸n en l铆nea.
Inversionistas y analistas podr谩n acceder al evento a trav茅s del sitio web de relaciones con inversionistas de la compa帽铆a, y los analistas tendr谩n la opci贸n de participar en la sesi贸n de preguntas y respuestas. Una versi贸n archivada de la transmisi贸n estar谩 disponible despu茅s del evento en vivo.
Wave Life Sciences (NASDAQ:WVE)電� RNA 鞚橃暯頀堨潉 鞝勲鞙茧 頃橂姅 鞛勳儊 雼硠鞚� 靸濍獏瓿淀暀 須岇偓搿�, 2025雲� 2攵勱赴 鞛 鞁れ爜 氚滍憸 旎嵓霟办姢 旖�鞚� 2025雲� 7鞗� 30鞚� 鞓れ爠 8鞁� 30攵�(霃欕秬鞁滉皠)鞐� 鞓堨爼頃橁碃 鞛堨姷雼堧嫟. 須岇偓電� 鞗轨簮鞀ろ姼毳� 韱淀暣 鞛 鞁れ爜鞚� 氚滍憸頃橁碃 靷梾 順勴櫓鞚� 鞐呺嵃鞚错姼頃� 鞓堨爼鞛呺媹雼�.
韴瀽鞛愳檧 鞎犽剱毽姢韸鸽姅 須岇偓鞚� 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼毳� 韱淀暣 頄夓偓鞐� 鞝戩啀頃� 靾� 鞛堨溂氅�, 鞎犽剱毽姢韸鸽姅 歆堨潣鞚戨嫷 靹胳厴鞐� 彀胳棳頃� 靾� 鞛堧姅 鞓奠厴鞚� 鞝滉车霅╇媹雼�. 靸濎瓿� 膦呺 頉� 鞗轨簮鞀ろ姼 雲鬼檾氤鸽弰 鞝滉车霅� 鞓堨爼鞛呺媹雼�.
Wave Life Sciences (NASDAQ:WVE), une soci茅t茅 biotechnologique en phase clinique sp茅cialis茅e dans les m茅dicaments 脿 base d'ARN, a programm茅 sa conf茅rence t茅l茅phonique sur les r茅sultats financiers du deuxi猫me trimestre 2025 pour le 30 juillet 2025 脿 8h30 ET. La soci茅t茅 pr茅sentera les r茅sultats financiers et fournira des mises 脿 jour commerciales lors du webinaire.
Les investisseurs et analystes pourront acc茅der 脿 l'茅v茅nement via le site web des relations investisseurs de la soci茅t茅, les analystes ayant la possibilit茅 de participer 脿 la session de questions-r茅ponses. Une version archiv茅e du webinaire sera disponible apr猫s l'茅v茅nement en direct.
Wave Life Sciences (NASDAQ:WVE), ein biotechnologisches Unternehmen in der klinischen Phase, das sich auf RNA-Medikamente spezialisiert hat, hat seine Telefonkonferenz zur Ver枚ffentlichung der Finanzergebnisse f眉r das zweite Quartal 2025 f眉r den 30. Juli 2025 um 8:30 Uhr ET angesetzt. Das Unternehmen wird w盲hrend des Webcasts die Finanzergebnisse pr盲sentieren und Gesch盲ftsaktualisierungen geben.
Investoren und Analysten k枚nnen 眉ber die Investor-Relations-Website des Unternehmens an der Veranstaltung teilnehmen, wobei Analysten die M枚glichkeit haben, an der Fragerunde teilzunehmen. Eine Aufzeichnung des Webcasts wird nach der Live-Veranstaltung verf眉gbar sein.
- None.
- None.
CAMBRIDGE, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd.聽(Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and conference call at 8:30 a.m. ET on Wednesday, July 30, 2025, to review the company鈥檚 second quarter 2025 financial results and provide business updates.
The webcast and conference call may be accessed by visiting 鈥淚nvestor Events鈥� on the investors section of the Wave Life Sciences website: .
Analysts planning to participate during the Q&A portion of the live call can join the conference call at the audio-conferencing link .
Following the live event, an archived version of the webcast will be available on the Wave Life Sciences website.
About聽Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. Wave鈥檚 RNA medicines platform, PRISM庐, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Its toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. Wave鈥檚 diversified pipeline includes clinical programs in Alpha-1 antitrypsin deficiency, Duchenne muscular dystrophy, Huntington鈥檚 disease, and obesity, as well as several preclinical programs utilizing the company鈥檚 broad RNA therapeutics toolkit. Driven by the calling to 鈥淩eimagine Possible鈥�, Wave is leading the charge toward a world in which human potential is no longer hindered by the burden of disease. Wave is headquartered in Cambridge, MA. For more information on Wave鈥檚 science, pipeline and people, please visit and follow Wave on (formerly Twitter) and .
Contact:
Kate Rausch
VP, Corporate Affairs and Investor Relations
+1 617-949-4827
Investors:
Media:
FAQ
When is Wave Life Sciences (WVE) reporting Q2 2025 earnings?
How can investors access Wave Life Sciences Q2 2025 earnings call?
What will be discussed in Wave Life Sciences Q2 2025 earnings call?
Will there be a Q&A session during Wave Life Sciences earnings call?
